Breast Cancer pp 245-254 | Cite as

Local-Regional Recurrence in Breast Cancer

  • Thomas J. Kearney
  • David A. August
Part of the Current Clinical Oncology book series (CCO)


The problem of local-regional recurrence of breast cancer confronts a substantial number of patients who are initially treated with apparent success. The percentage of patients who experience such recurrence varies depending on the initial stage of the disease and the form of initial breast treatment. Patients with stage I breast cancer treated with a clean margin lumpectomy and postoperative radiation therapy will have recurrence rates in the conserved breast of about 5%. In contrast, patients with Stage IIIB, initially inoperable, disease will have recurrence rates of greater than 25% on the chest wall even in the setting of successful neoadjuvant chemotherapy, mastectomy, and postoperative radiation. In patients who suffer a local-regional recurrence, one-third will have synchronous distant failure. Others subsequently develop distant disease following local-regional recurrence.


Local Recurrence Axillary Dissection Breast Conservation Ipsilateral Breast Tumor Recurrence Axillary Recurrence 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Albertini JJ, Lyman GH, Cox C, et al. (1996) Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA 276, 1818–1822.Google Scholar
  2. Connolly JL, Harris JR, Schnitt Si (1995) Understanding the distribution of cancer within the breast is important for optimizing breast-conserving treatment. Cancer 76, 1–3.Google Scholar
  3. Fisher B, Dignam J, Wolmark N, et al. (1998) Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from the National Surgical Adjuvant Breast and Bowel project B-17. J. Clin. Oncol. 16, 441–452.PubMedGoogle Scholar
  4. Fisher B, Redmond C, Fisher E (1985) Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N. Engl. J. Med. 312, 674–681.PubMedCrossRefGoogle Scholar
  5. Fisher B, Redmond C, Poisson R (1989) Eight year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer. N. Engl. J. Med. 320, 822–828.PubMedCrossRefGoogle Scholar
  6. Fortin A, Larochelle M, Laverdiere J, Lavertu S, Tremblay D (1999) Local failure is responsible for the decrease in survival for patients with breast cancer treated with conservative surgery and postoperative radiotherapy. J. Clin. Oncol. 17, 101–109.PubMedGoogle Scholar
  7. Fowble B (1997) Postmastectomy radiation: then and now. Oncology 11, 213–228.PubMedGoogle Scholar
  8. Fowble B, Gray R, Gilchrist K, Goodman RL, Taylor S, Tormey DC (1988) Identification of a subgroup of patients with breast cancer and histologically positive axillary nodes receiving adjuvant chemotherapy who may benefit from postoperative radiotherapy. J. Clin. Oncol. 6, 1107–1117.PubMedGoogle Scholar
  9. Giuliano AE, Kirgan DM, Guenthler JM, Morton DL (1994) Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann. Surg. 220, 391–401.PubMedCrossRefGoogle Scholar
  10. Haffty BG, Reiss M, Beinfield M, Fischer D, Ward B, McKhann C (1996) Ipsilateral breast tumor recurrence as a predictor of distant disease: implications for systemic therapy at the time of local relapse. J. Clin. Oncol. 14, 52–57.PubMedGoogle Scholar
  11. Hait WN, August DA, Haffty BG (1999) Expert Consultations in Breast Cancer — Critical Pathways and Clinical Decision Making. Marcel Dekker, New York.Google Scholar
  12. Holland R, Veling S, Mravunac M (1985) Histologic multifocality of Tis, T1–2 breast carcinomas: implication for clinical trials of breast conserving treatment. Cancer 56, 979.PubMedCrossRefGoogle Scholar
  13. Kim SH, Simkovich-Heerdt A, Tran KN (1998) Women 35 years of age or younger have higher localregional relapse rates after undergoing breast conservation therapy. J. Am. Coll. Surg. 187, 1–8.PubMedCrossRefGoogle Scholar
  14. Krag D, Weaver D, Ashikaga T, et al. (1998) The sentinel node in breast cancer—a multicenter validation trial. N. Engl. J. Med. 339, 941–946.PubMedCrossRefGoogle Scholar
  15. Overgaard M, Hansen PS, Overgaard J, et al. (1997) Postoperative radiotherapy in high-risk premenopausalGoogle Scholar
  16. women with breast cancer who receive adjuvant chemotherapy. N. Engl. J. Med. 337, 949–955.Google Scholar
  17. Ragaz J, Jackson SM, Le N, et al. (1997) Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N. Engl. J. Med. 337, 956–962.PubMedCrossRefGoogle Scholar
  18. Recht A, Gray R, Davidson NE, et al. (1999) Local-regional failure 10 years after mastectomy and adjuvant chemotherapy with or without tamoxifen without irradiation: Experience of the Eastern Cooperative Oncology Group. J. Clin. Oncol. 17, 1689–1700.PubMedGoogle Scholar
  19. Schwartz GF, Finkel GC, Garcia JC, Patchefsky AS (1992) Subclinical ductal carcinoma in situ of the breast: treatment by local excision and surveillance alone. Cancer 15, 2468–2474.CrossRefGoogle Scholar
  20. Silverstein MJ, Lagios MD, Craig PH, et al. (1996) A prognostic index for ductal carcinoma in situ of the breast. Cancer 77, 2267–2192.PubMedCrossRefGoogle Scholar
  21. Veronesi U, Luini A, Galimberti V (1994) Conservative approaches for the management of stage 1/1I carcinoma of the breast: Milan Cancer Institute trials. World J. Surg. 18, 70.PubMedCrossRefGoogle Scholar
  22. Winchester DJ, Menck HR, Winchester DP (1997) National treatment trends for ductal carcinoma in situ of the breast. Arch. Surg. 132, 660–665.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2002

Authors and Affiliations

  • Thomas J. Kearney
  • David A. August

There are no affiliations available

Personalised recommendations